Discovery of novel, potent, selective and orally bioavailable HPK1 inhibitor for enhancing the efficacy of anti-PD-L1 antibody
Autor: | Zeng, Shenxin a, b, c, ∗∗, Wu, Mingfei d, Jin, Yuyuan a, b, c, Ye, Yingqiao a, b, c, Xia, Heye a, b, c, Chen, Xinyi a, b, c, Che, Jinxin d, Wang, Zunyuan a, b, c, Wu, Ying a, Dong, Xiaowu d, ∗∗∗, Chen, Yinqiao a, ∗∗∗∗, Huang, Wenhai a, b, c, ∗ |
---|---|
Zdroj: | In European Journal of Medicinal Chemistry 5 March 2024 267 |
Databáze: | ScienceDirect |
Externí odkaz: |